-+ 0.00%
-+ 0.00%
-+ 0.00%

Lifecore Biomedical signs tech transfer, commercial manufacturing deal for marketed neurology injectable suspension

PUBT·06/15/2026 11:05:14
Listen to the news
Lifecore Biomedical signs tech transfer, commercial manufacturing deal for marketed neurology injectable suspension
  • Lifecore Biomedical signed a new agreement with a global pharmaceutical company to support commercial production of a marketed neurology injectable suspension.
  • Contract covers technical transfer services for the product’s commercial manufacturing.
  • Marks the company’s seventh late-stage program agreement in the past seven months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifecore Biomedical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606150705PRIMZONEFULLFEED9746541) on June 15, 2026, and is solely responsible for the information contained therein.